NSW Showcase: TIA and MTPConnect | Recent Visits to Leading Australian Research Facilities Read More » 23 July 2024
Therapeutic Innovation Australia and Phenomics Australia partnership reinforces commitment to address the medical products challenge Read More » 3 July 2024
Funding boost from two state governments to enhance translational research infrastructure Read More » 17 May 2024
New company established to operate NSW’s world-leading viral vector facility Read More » 26 February 2024
TIA and Phenomics Australia partnership reinforces commitment to bridge the translational gap Read More » 13 December 2023
Compounds Australia enters a new era of compound storage, access, and supply Read More » 8 December 2023
TIA-supported facility helps kick-start an Australian-developed cancer drug that has now been approved by the US FDA Read More » 17 October 2023
How TIA is helping infectious disease researchers build translational skills Read More » 23 June 2023
New biotech company receives funding to halt the progression of kidney disease Read More » 6 June 2023
How TIA is helping to accelerate the development of Australian COVID-19 treatments Read More » 22 November 2022
Prescient Therapeutics Limited building LEGO-like solutions to address rapidly mutating cancers Read More » 24 October 2022
